Cadila Launches Tarzed For Early-stage Breast Cancer
24th Jan, 2022 | NewsCadila Pharmaceuticals has launched trastuzumab under the brand name Tarzed. It is a humanized monoclonal antibody and is recommended for HER2-positive early-stage breast cancer and metastatic breast cancer.
Navjeevan Express
India News Republic
Health Vision
Free Express
ET Healthworld
ET Express Pharma
Bio Voice
Prabhat
